...
首页> 外文期刊>European journal of gastroenterology and hepatology >Serum fetuin-B level is an independent marker for nonalcoholic fatty liver disease in patients with type 2 diabetes
【24h】

Serum fetuin-B level is an independent marker for nonalcoholic fatty liver disease in patients with type 2 diabetes

机译:血清Fetuin-B水平是2型糖尿病患者的非酒精性脂肪肝病的独立标志物

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective Previous studies have assessed serum fetuin-B and its relation to nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM) and as a link between them through inducing insulin resistance (IR). Therefore, we examined the potential of serum fetuin-B to be an independent marker for NAFLD in patients with T2DM. Patients and methods The study group consisted of 270 patients with T2DM. Clinical and laboratory features were evaluated. The NAFLD severity was graded by ultrasound into three subgroups: grade 0 (no fatty liver), grade 1 (mild fatty liver), and grade 2-3 (medium to severe fatty liver). Fetuin-B, retinol-binding protein-4, and adiponectin were measured. Results Patients with grade 2-3 NAFLD had high fetuin-B levels in comparison with non-NAFLD group. Age and sex adjusted fetuin-B demonstrated positive correlations with triglycerides, gamma-glutamyl transferase, fasting plasma glucose, 2-h postprandial plasma glucose, homeostasis model assessment of IR, fasting insulin, glycated hemoglobin, high-sensitivity C-reactive protein, and estimated glomerular filtration rate, but it had a negative correlation with serum creatinine. Adiponectin level was decreased with increasing NAFLD severity, but no difference was found in retinol-binding protein-4. The estimated odds ratio (OR) for the occurrence of grade 2-3 NAFLD was increased significantly with increasing levels of fetuin-B (OR: 3.92; 95% confidence interval: 2.14-8.32 vs. OR: 8.91; 95% confidence interval: 4.22-18.41). The OR of fetuin-B in the uppermost tertile group was still significant after controlling for homeostasis model assessment of IR, glycated hemoglobin, waist circumference, BMI, hepatic enzymes, high-density lipoprotein cholesterol, triglycerides, and high-sensitivity C-reactive protein. Conclusions Our study demonstrated that serum fetuin-B had an independent association with NAFLD in patients with T2DM.
机译:目的先前的研究已经评估了血清Fetuin-B及其与非酒精性脂肪肝疾病(NAFLD)和2型糖尿病(T2DM)的关系以及通过诱导胰岛素抵抗(IR)之间的链接。因此,我们将血清Fetuin-B的潜力视为T2DM患者NAFLD的独立标志物。患者和方法研究组由270例T2DM组成。评估临床和实验室特征。 NAFLD严重程度通过超声分为三个亚组:0级(无脂肪肝),1级(轻度脂肪肝)和2-3级(​​中等至严重脂肪肝)。测量胎儿-B,视黄醇结合蛋白-4和脂联素。结果2-3级NAFLD患者与非NAFLD组相比具有高胎素-B水平。年龄和性别调整的胎儿-B与甘油三酯,γ-谷氨酸转移酶,空腹血浆,2-H后血浆葡萄糖,IR的稳态性模型评估,IR,空腹胰岛素,糖化性血红蛋白,高敏感性C-反应蛋白,以及估计肾小球过滤速率,但它与血清肌酐的负相关性。随着NAFLD严重程度的增加,脂联素水平降低,但在视黄醇结合蛋白-4中没有发现差异。估计的差异比例(或)患者2-3级NAFLD的发生量显着增加,随着胎儿-B的增加(或3.92; 95%置信区间:2.14-8.32与或:8.91; 95%置信区间: 4.22-18.41)。在控制IR,糖化血红蛋白,腰围,BMI,肝酶,高密度脂蛋白胆固醇,甘油三酯和高灵敏度C-反应蛋白的IR 。结论我们的研究表明,血清Fetuin-B与T2DM患者与NAFLD进行独立关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号